Pneumococcal Vaccine Market Size, Share, Growth Insights and Report 2024-2032 | GSK plc, Pfizer Inc., Merck KGaA

𝐌𝐚𝐫𝐤𝐞𝐭 𝐎𝐮𝐭𝐥𝐨𝐨𝐤:
• 𝐓𝐡𝐞 𝐩𝐧𝐞𝐮𝐦𝐨𝐜𝐨𝐜𝐜𝐚𝐥 𝐯𝐚𝐜𝐜𝐢𝐧𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐬𝐢𝐳𝐞 𝐰𝐚𝐬 𝐯𝐚𝐥𝐮𝐞𝐝 𝐚𝐭 𝐔𝐒𝐃 𝟖.𝟐𝟕 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝟐𝟎𝟐𝟑.
• 𝐓𝐡𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐢𝐬 𝐞𝐱𝐩𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐞𝐱𝐩𝐚𝐧𝐝 𝐚𝐭 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 𝟔.𝟒% 𝐟𝐫𝐨𝐦 𝟐𝟎𝟐𝟒 𝐭𝐨 𝟐𝟎𝟑𝟐.
• 𝐓𝐡𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐢𝐬 𝐞𝐱𝐩𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐠𝐫𝐨𝐰 𝐭𝐨 𝐔𝐒𝐃 𝟏𝟒.𝟒𝟑 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟐.

𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰:
Pneumococcal vaccines are created to safeguard children and adults from pneumonia-induced acute and severe infections. There are mainly two types of pneumococcal vaccines in existence: pneumococcal conjugate vaccine (PCV) and pneumococcal polysaccharide vaccine (PPSV). These vaccines are made up of various serotypes of pneumococcus that are combined to create a single dose for immunizing both children and adults. Various serotypes cause distinct pneumonia infections, with specific serotypes causing invasive pneumococcal disease, a more severe form of the illness.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐞 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.polarismarketresearch.com/industry-analysis/pneumococcal-vaccine-market/request-for-sample

𝐆𝐫𝐨𝐰𝐭𝐡 𝐅𝐚𝐜𝐭𝐨𝐫𝐬 𝐚𝐧𝐝 𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬:
The increasing prevalence of pneumococcal disease in people of all ages is fueling the demand for pneumococcal vaccines in the upcoming years. Furthermore, government initiatives and health policies promoting widespread vaccination are the main drivers of the market. As governments place greater emphasis on vaccination to prevent diseases, the market for pneumococcal vaccines is projected to see significant expansion.

𝐊𝐞𝐲 𝐏𝐚𝐫𝐭𝐢𝐜𝐢𝐩𝐚𝐧𝐭𝐬:
With so many businesses involved, the market is projected to become more competitive as it continues to grow.
Some of the major players participating in the pneumococcal vaccine market:
• GSK plc
• Pfizer Inc.
• Merck KGaA
• Serum Institute of India Pvt. Ltd.
• CSL Ltd.
• Sanofi S.A.
• Walvax Biotechnology Co., Ltd.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐟𝐨𝐫 𝐚 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭 𝐨𝐧 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐁𝐞𝐟𝐨𝐫𝐞 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞:
https://www.polarismarketresearch.com/industry-analysis/pneumococcal-vaccine-market/request-for-discount-pricing

𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧:
The pneumococcal vaccine market is primarily segmented based on the vaccine type, product type, end user, and region. Based on vaccine type analysis, in 2023, the pneumococcal polysaccharide vaccine segment held the largest market share. It covers a wide range of pneumococcal strains and has a proven track record in preventing severe infections in adults, especially those with pre-existing health issues.
Furthermore, according to the product type analysis, during the projection period, the Synflorix segment is anticipated to witness the highest CAGR due to its affordability; Synflorix is especially popular in countries with limited budgets, increasing its market share. The rapid growth rate of this pneumococcal vaccine is largely fueled by the increasing demand in developing regions, surpassing other similar vaccines.

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐓𝐡𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐞𝐫𝐞:
https://www.polarismarketresearch.com/industry-analysis/pneumococcal-vaccine-market

𝐏𝐧𝐞𝐮𝐦𝐨𝐜𝐨𝐜𝐜𝐚𝐥 𝐕𝐚𝐜𝐜𝐢𝐧𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬
• The pneumococcal polysaccharide vaccine (PPV) segment accounted for the largest market share in 2023 primarily due to global acceptance and easy availability.
• The Pneumococcal conjugate vaccine (PCV) segment is expected to witness the highest growth over the study period, as PCV covers more range of the streptococcus pneumoniae.
• The Prevnar 13 segment accounted for the largest market share in 2023, as it caters to a wider range of age, and is more efficient in treating the disease.
• The Asia Pacific is projected to register the fastest growth over the study period, attributable to the increasing investment in pneumococcal vaccine development.
• The global players are GSK plc, Pfizer Inc, Merck, Serum Institute, CSL Ltd., and Sanofi.

𝐌𝐨𝐫𝐞 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐋𝐚𝐭𝐞𝐬𝐭 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐛𝐲 𝐏𝐨𝐥𝐚𝐫𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡:
𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐓𝐫𝐢𝐚𝐥 𝐎𝐮𝐭𝐬𝐨𝐮𝐫𝐜𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭
https://www.polarismarketresearch.com/industry-analysis/clinical-trials-outsourcing-market

𝐌𝐞𝐝𝐢𝐜𝐚𝐥 𝐓𝐚𝐩𝐞𝐬 𝐚𝐧𝐝 𝐁𝐚𝐧𝐝𝐚𝐠𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭
https://www.polarismarketresearch.com/industry-analysis/medical-tapes-and-bandages-market

𝐌𝐢𝐜𝐫𝐨𝐛𝐢𝐨𝐦𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐫𝐞𝐩𝐚𝐫𝐚𝐭𝐢𝐨𝐧 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲 𝐌𝐚𝐫𝐤𝐞𝐭
https://www.polarismarketresearch.com/industry-analysis/microbiome-sample-preparation-technology-market

𝐈𝐬𝐨𝐭𝐡𝐞𝐫𝐦𝐚𝐥 𝐍𝐮𝐜𝐥𝐞𝐢𝐜 𝐀𝐜𝐢𝐝 𝐀𝐦𝐩𝐥𝐢𝐟𝐢𝐜𝐚𝐭𝐢𝐨𝐧 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲 𝐌𝐚𝐫𝐤𝐞𝐭
https://www.polarismarketresearch.com/industry-analysis/isothermal-nucleic-acid-amplification-technology-market

𝐏𝐫𝐨𝐭𝐞𝐢𝐧 𝐄𝐱𝐩𝐫𝐞𝐬𝐬𝐢𝐨𝐧 𝐌𝐚𝐫𝐤𝐞𝐭
https://www.polarismarketresearch.com/industry-analysis/protein-expression-market

Contact:
Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter

About Polaris Market Research & Consulting, Inc:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.

This release was published on openPR.